Gabriel Schwartz, NP
Family · San Francisco, CANPI 1598148173
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $102,118 of the $165,744 with a category attached, or 61.6%. 8 manufacturers reported payments, led by Incyte Corporation at 37.5% of the total. Reporting peaked in 2024 at $57,896 and has fallen 63.7% since, to $21,010 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $468.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$62K
- AstraZeneca$58K
- Eisai Inc.$23K
- Takeda Pharmaceuticals U.S.A., Inc.$17K
- Exelixis Inc.$5K
- Amgen$164
- plus $218 from 2 others
What the payments were for
- Consulting fees$15,6259%
- Speaking & faculty fees$102,11862%
- Travel & lodging$41,32225%
- Food & beverage$6,4584%
- Education$2210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 147 | $62,169 |
| AstraZeneca | 100 | $58,006 |
| Eisai Inc. | 69 | $23,049 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $17,212 |
| Exelixis Inc. | 12 | $4,926 |
| Amgen | 2 | $164 |
| AbbVie | 1 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$165,744 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in San Francisco
- Annika EhrlichSan Francisco$128K
- Monica VolzSan Francisco$96K
- Bethany KinseySan Francisco$33K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.